SCHEMBL26719282

SCHEMBL26719282

CCOc1nc(-c2c[nH]c3c(C#N)cccc23)cnc1NC1CCN(I)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 3/20 0.40
▸ GSK3B P49841 2/20 0.40
▸ NFATC1 O95644 1/20 0.40
▸ CCNT1 O60563 2/20 0.38
▸ CCNK O75909 2/20 0.38
▸ CCNE1 P24864 2/20 0.38
▸ CDK2 P24941 2/20 0.38
▸ CDK9 P50750 2/20 0.38
▸ CDK12 Q9NYV4 2/20 0.38
▸ JAK2 O60674 11/20 0.37
▸ JAK3 P52333 10/20 0.37
▸ DYRK1B Q9Y463 1/20 0.34
▸ JAK1 P23458 2/20 0.34
▸ TYK2 P29597 2/20 0.34
▸ CDK7 P50613 2/20 0.33
▸ CCNH P51946 2/20 0.33
▸ MNAT1 P51948 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ LRRK2 Q5S007 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25028688 0.85 CCNT1 (0.50) DYRK1AGSK3BNFATC1CCNT1CCNK
SCHEMBL26719608 0.83 JAK3 (0.43) DYRK1AGSK3BNFATC1CCNT1CCNK
Formic Acid SCHEMBL29005614 0.81 CCNT1 (0.47) DYRK1AGSK3BNFATC1CCNT1CCNK
SCHEMBL26716959 0.80 DYRK1A (0.40) DYRK1AGSK3BNFATC1CCNT1CCNK
SCHEMBL26718632 0.80 DYRK1A (0.41) DYRK1AGSK3BNFATC1CCNT1CCNK
SCHEMBL25027651 0.80 JAK3 (0.47) CCNKCDK12JAK2JAK3
SCHEMBL29364416 0.80 JAK3 (0.47) CCNKCDK12JAK2JAK3
SCHEMBL25027523 0.80 JAK3 (0.47) CCNKCDK12JAK2JAK3
SCHEMBL29363962 0.80 JAK3 (0.47) CCNKCDK12JAK2JAK3
SCHEMBL25028660 0.80 JAK3 (0.47) CCNKCDK12JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS NIDO BIOSCIENCES INC (US) 2023-11-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348439-A1 INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS AR, FSHR, NR5A1 DYRK1A 1097/4885GSK3B 441/4885NFATC1 1359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback